These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 31231997)

  • 1. [Biologics for targeting inflammatory cytokines and their clinical application].
    Chen J; Xie M; Li L; Liu D; Liu M
    Sheng Wu Gong Cheng Xue Bao; 2019 Jun; 35(6):1009-1020. PubMed ID: 31231997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations.
    Rider P; Carmi Y; Cohen I
    Int J Cell Biol; 2016; 2016():9259646. PubMed ID: 28083070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders.
    Balato A; Scala E; Balato N; Caiazzo G; Di Caprio R; Monfrecola G; Raimondo A; Lembo S; Ayala F
    Expert Opin Biol Ther; 2017 Nov; 17(11):1363-1374. PubMed ID: 28791896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine blockade in inflammatory bowel diseases.
    Perrier C; Rutgeerts P
    Immunotherapy; 2011 Nov; 3(11):1341-52. PubMed ID: 22053885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bovine tumor necrosis factor alpha decoy receptors on cell death and inflammatory cytokine kinetics: potential for bovine inflammation therapy.
    Fujisawa S; Konnai S; Okagawa T; Maekawa N; Tanaka A; Suzuki Y; Murata S; Ohashi K
    BMC Vet Res; 2019 Feb; 15(1):68. PubMed ID: 30819151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamers Against Pro- and Anti-Inflammatory Cytokines: A Review.
    Boshtam M; Asgary S; Kouhpayeh S; Shariati L; Khanahmad H
    Inflammation; 2017 Feb; 40(1):340-349. PubMed ID: 27878687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory cytokine levels, disease activity, and function of patients with rheumatoid arthritis treated with combined conventional disease-modifying antirheumatic drugs or biologics.
    Osiri M; Wongpiyabovorn J; Sattayasomboon Y; Thammacharoenrach N
    Clin Rheumatol; 2016 Jul; 35(7):1673-81. PubMed ID: 27188857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines, acute-phase proteins, and hormones: IL-1 and TNF-alpha production in contact-mediated activation of monocytes by T lymphocytes.
    Burger D; Dayer JM
    Ann N Y Acad Sci; 2002 Jun; 966():464-73. PubMed ID: 12114305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings.
    Dinarello CA
    J Biol Regul Homeost Agents; 1997; 11(3):91-103. PubMed ID: 9498158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of biologics in treatment of connective tissue disease-associated interstitial lung disease.
    Sharp C; Dodds N; Mayers L; Millar AB; Gunawardena H; Adamali H
    QJM; 2015 Sep; 108(9):683-8. PubMed ID: 25614613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis.
    Mateen S; Zafar A; Moin S; Khan AQ; Zubair S
    Clin Chim Acta; 2016 Apr; 455():161-71. PubMed ID: 26883280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-modulating strategies and newer cytokine targets for arthritis therapy.
    Venkatesha SH; Dudics S; Acharya B; Moudgil KD
    Int J Mol Sci; 2014 Dec; 16(1):887-906. PubMed ID: 25561237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review.
    Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; Llurba E; Gris JM
    Clin Rev Allergy Immunol; 2017 Aug; 53(1):40-53. PubMed ID: 28054230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modern anti-cytokine therapy of autoimmune diseases.
    Astrakhantseva IV; Efimov GA; Drutskaya MS; Kruglov AA; Nedospasov SA
    Biochemistry (Mosc); 2014 Dec; 79(12):1308-21. PubMed ID: 25716724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current and prospective biologics and small molecules in the treatment of inflammatory bowel diseases].
    Buc M
    Vnitr Lek; 2018; 64(3):280-289. PubMed ID: 29766731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics.
    Katsanos KH; Papadakis KA
    Gut Liver; 2017 Jul; 11(4):455-463. PubMed ID: 28486793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis, Cardiovascular Events, and Biologics: Lights and Shadows.
    Caiazzo G; Fabbrocini G; Di Caprio R; Raimondo A; Scala E; Balato N; Balato A
    Front Immunol; 2018; 9():1668. PubMed ID: 30150978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To Extinguish the Fire from Outside the Cell or to Shutdown the Gas Valve Inside? Novel Trends in Anti-Inflammatory Therapies.
    Marcuzzi A; Piscianz E; Valencic E; Monasta L; Vecchi Brumatti L; Tommasini A
    Int J Mol Sci; 2015 Sep; 16(9):21277-93. PubMed ID: 26370962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.